The clustering typing based on the expression levels of COL10A1/FAP/FN1 of COVID-19 signature genes provides a new typing approach for PC, enabling a more refined analysis of PC and providing a good reference for the sophisticated treatment of PC and further clinical studies. This evidence concerns the gene COL10A1 and COVID-19.